(Q40343144)

19 September 2017

Cyclooxygenase-2 (COX-2) is directly involved but not decisive in proliferation of human hepatocellular carcinoma cells (English)

1 reference

19 September 2017

Joong-Won Park

1

1 reference

19 September 2017

Jung Eun Park

2

1 reference

19 September 2017

Jung Ahn Lee

3

1 reference

19 September 2017

Chang-Woo Lee

4

1 reference

19 September 2017

Chang-Min Kim

5

1 reference

19 September 2017

6 December 2005

1 reference

Journal of Cancer Research and Clinical Oncology

19 September 2017

1 reference

19 September 2017

132

1 reference

19 September 2017

3

1 reference

19 September 2017

184-192

1 reference

https://scigraph.springernature.com/pub.10.1007/s00432-005-0060-x

19 September 2017

0 references

cites work

Proapoptotic and antiproliferative potential of selective cyclooxygenase-2 inhibitors in human liver tumor cells

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00432-005-0060-X

Cancer Incidence in Korea.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00432-005-0060-X

Inhibition of prostaglandin synthesis up-regulates cyclooxygenase-2 induced by lipopolysaccharide and peroxisomal proliferators

21 January 2018

1 reference

12 December 2020

The MDR phenotype is associated with the expression of COX-2 and iNOS in a human hepatocellular carcinoma cell line

1 reference

12 December 2020

Altered expression of E-cadherin in hepatocellular carcinoma: correlations with genetic alterations, beta-catenin expression, and clinical features

1 reference

12 December 2020

The molecular perspective: cyclooxygenase-2.

1 reference

12 December 2020

1 reference

12 December 2020

Inhibitors of cyclo-oxygenase 2: a new class of anticancer agents?

1 reference

12 December 2020

Differential expression of cyclooxygenase-2 (COX-2) in human bile duct epithelial cells and bile duct neoplasm.

1 reference

12 December 2020

Cyclooxygenase-2 promotes hepatocellular carcinoma cell growth through Akt activation: evidence for Akt inhibition in celecoxib-induced apoptosis

1 reference

12 December 2020

The hepatitis B virus X protein promotes tumor cell invasion by inducing membrane-type matrix metalloproteinase-1 and cyclooxygenase-2 expression

1 reference

12 December 2020

Cyclooxygenase-2 expression in hepatocellular carcinoma

1 reference

12 December 2020

Cyclooxygenase-2 inhibitors suppress the growth of human hepatocellular carcinoma implants in nude mice

1 reference

12 December 2020

NS-398, a selective cyclooxygenase 2 inhibitor, inhibited cell growth and induced cell cycle arrest in human hepatocellular carcinoma cell lines

1 reference

12 December 2020

Expression of cyclooxygenase-2 in chronic hepatitis B and the effects of anti-viral therapy.

1 reference

12 December 2020

Survivin: a novel target for indomethacin-induced gastric injury

1 reference

12 December 2020

Treatment of hepatocellular carcinoma

1 reference

12 December 2020

Expressions of cyclooxygenase-2 and prostaglandin E-receptors in carcinoma of the gallbladder: crucial role of arachidonate metabolism in tumor growth and progression.

1 reference

12 December 2020

Biochemistry of cyclooxygenase (COX)-2 inhibitors and molecular pathology of COX-2 in neoplasia

1 reference

12 December 2020

The role of cyclooxygenases in inflammation, cancer, and development

1 reference

12 December 2020

A system for stable expression of short interfering RNAs in mammalian cells

1 reference

12 December 2020

Induction of G0/G1 cell cycle arrest in ovarian carcinoma cells by the anti-inflammatory drug NS-398, but not by COX-2-specific RNA interference.

1 reference

12 December 2020

Hepatocellular carcinoma: is there a potential for chemoprevention using cyclooxygenase-2 inhibitors?

1 reference

12 December 2020

Expression of cyclooxygenase-2 in human hepatocellular carcinoma: relevance to tumor dedifferentiation

1 reference

12 December 2020

Regulation of cyclooxygenase-2 expression by the Wnt and ras pathways.

1 reference

12 December 2020

RNAi: gene-silencing in therapeutic intervention

1 reference

12 December 2020

Coexpression of inducible nitric oxide synthase and COX-2 in hepatocellular carcinoma and surrounding liver: possible involvement of COX-2 in the angiogenesis of hepatitis C virus-positive cases.

1 reference

12 December 2020

Expression of cyclooxygenase-2 (COX-2) in hepatocellular carcinoma and growth inhibition of hepatoma cell lines by a COX-2 inhibitor, NS-398.

1 reference

12 December 2020

COX-2 inhibits Fas-mediated apoptosis in cholangiocarcinoma cells

1 reference

12 December 2020

Rationale and feasibility of chemoprovention of hepatocellular carcinoma by cyclooxygenase-2 inhibitors

1 reference

12 December 2020

10.1007/S00432-005-0060-X

Identifiers

DOI

1 reference

19 September 2017

1 reference